Scotland Stevens
Public Equity Partner at OrbiMed
New York City, New York
Scotland Stevens, Public Equity Partner at OrbiMed is an active investor based in New York City, New York. This profile covers what Scotland Stevens backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCPEInvestor
- Stages
- SeedSeries A
- Invests in
- FintechHealthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseIoT & Connected DevicesGaming & Entertainment
- Location
- New York City, New York
- Typical check
- $625K
- Past investments
- 91
Notable investments
Edgewise Therapeutics
Syros PharmaceuticalsYisheng Biopharma
Evox Therapeutics
Olema Oncology
Aerin Medical
CoreMapNewMed Medical
BioShin
Scribe Therapeutics
X4 Pharmaceuticals
Visen PharmaceuticalsHow to reach Scotland Stevens
Angels and operators like Scotland Stevens reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Scotland Stevens
Frequently Asked Questions
What does Scotland Stevens invest in?
Scotland Stevens invests in Fintech, Healthcare & Biotech, Digital Health & HealthTech and Biotech & Pharma, typically at Seed and Series A. Match your sector and stage, then reach out with a personalized pitch.
What stage does Scotland Stevens invest at?
Scotland Stevens typically invests at Seed and Series A. Lead with traction that fits the stage when you reach out.
What is Scotland Stevens's typical check size?
Scotland Stevens typically writes checks around $625K. Use it as a signal for whether your raise fits their stage.
How do I contact Scotland Stevens?
Unlock Scotland Stevens's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.